Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
- 1 March 1996
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 27 (3), 347-354
- https://doi.org/10.1016/s0272-6386(96)90357-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Roles of growth hormone and growth factors in the pathogenesis and treatment of kidney diseaseCurrent Opinion in Nephrology and Hypertension, 1993
- Hormones, autacoids, neurotransmitters, and growth factorsCurrent Opinion in Nephrology and Hypertension, 1993
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Outcome of Congestive Heart Failure, Dilated Cardiomyopathy, Hypertrophic Hyperkinetic Disease, and Ischemic Heart Disease in Dialysis PatientsAmerican Journal of Nephrology, 1990
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989
- Myocardial interstitial fibrosis in experimental uremia—Implications for cardiac complianceKidney International, 1988
- Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables.Hypertension, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Asymmetric Septal Hypertrophy in Uremic-Normotensive Patients on Regular HemodialysisNephron, 1985
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976